These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12906883)

  • 1. Animal experimentation in snake venom research and in vitro alternatives.
    Sells PG
    Toxicon; 2003 Aug; 42(2):115-33. PubMed ID: 12906883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A humane alternative to the measurement of the lethal effects (LD50) of non-neurotoxic venoms using hens' eggs.
    Sells PG; Ioannou P; Theakston RD
    Toxicon; 1998 Jul; 36(7):985-91. PubMed ID: 9690791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo but insensate model for the evaluation of antivenoms (ED(50)) using fertile hens' eggs.
    Sells PG; Laing GD; Theakston RD
    Toxicon; 2001 May; 39(5):665-8. PubMed ID: 11072045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Neutralisation of In Vitro Neurotoxicity of Asian and Australian Snake Neurotoxins and Venoms by Different Antivenoms.
    Silva A; Hodgson WC; Isbister GK
    Toxins (Basel); 2016 Oct; 8(10):. PubMed ID: 27763543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
    Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Gutiérrez JM; Vargas M; Segura Á; Herrera M; Villalta M; Solano G; Sánchez A; Herrera C; León G
    Front Immunol; 2020; 11():617429. PubMed ID: 33505403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
    Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B
    Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current technology for the industrial manufacture of snake antivenoms.
    León G; Vargas M; Segura Á; Herrera M; Villalta M; Sánchez A; Solano G; Gómez A; Sánchez M; Estrada R; Gutiérrez JM
    Toxicon; 2018 Sep; 151():63-73. PubMed ID: 29959968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal Testing.
    Verity EE; Stewart K; Vandenberg K; Ong C; Rockman S
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An examination of the activity of expired and mistreated commercial Australian antivenoms.
    O'Leary MA; Kornhauser RS; Hodgson WC; Isbister GK
    Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):937-42. PubMed ID: 19144367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA; Isbister GK
    Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivenom efficacy or effectiveness: the Australian experience.
    Isbister GK
    Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Villalta M; Vargas M; Sanz L; Lomonte B; Calvete JJ; León G
    Toxicon; 2013 Jul; 69():168-79. PubMed ID: 23201503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.